Lupus anticoagulant testing and anticoagulation do not mix: Quantitation of discrepant results and potential approaches to reduce false positives

British Journal of Haematology

Volumn 167, Issue 5, 2014, Pages 704-707

  Chandler, Jocelyn B ^a   Torres, Richard ^a,b   Rinder, Henry M ^a   Tormey, Christopher A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Anticoagulation; Antiphospholipid syndrome; Haematology testing discrepancy; Hypercoagulability testing; Lupus anticoagulant

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHATIDYLETHANOLAMINE; ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; CHILD; DIAGNOSTIC PROCEDURE; DILUTE RUSSELL VIPER VENOM TEST; FALSE POSITIVE RESULT; FEMALE; HUMAN; HYPERCOAGULABILITY; INFANT; INTERMETHOD COMPARISON; LETTER; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PHOSPHOLIPID NEUTRALIZATION TEST; PRIORITY JOURNAL; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BLOOD; CHEMISTRY; LABORATORY DIAGNOSIS; PROCEDURES; STANDARDS;

ANTICOAGULANTS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PROTHROMBIN TIME;

EID: 84925223047     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13030     Document Type: Letter

References (9)

1. Devreese, K., Peerlinck, K. & Hoylaerts, M.F. (2011) Diagnostic test combinations associated with thrombosis in lupus anticoagulant positive patients. Thrombosis and Haemostasis, 105, 736-738.
2. de Groot, P.G. & Urbanus, R.T. (2012) The significance of autoantibodies against beta2-glycoprotein I. Blood, 120, 266-274.
3. Jennings, I., Greaves, M., Mackie, I.J., Kitchen, S., Woods, T.A. & Preston, F.E.; on behalf of the UK National External Quality Assessment Scheme for Blood Coagulation (2002) Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. British Journal of Haematology, 119, 364-369.
4. Keeling, D., Mackie, I., Moore, G.W., Greer, I.A. & Greaves, M.; for the British Committee for Standards in Haematology (2012) Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology, 157, 47-58.
5. Male, C., Foulon, D., Hoogendoorn, H., Vegh, P., Silverman, E., David, M. & Mitchell, L. (2005) Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood, 106, 4152-4158.
6. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., DE Groot, PG, Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. & Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295-306.
7. Moore, G.W. (2014) Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Seminars in Thrombosis & Hemostasis, 40, 163-171.
8. Pengo, V., Tripodi, A., Reber, G., Rand, J.H., Ortel, T.L., Galli, M. & De Groot, P.G.; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis (2009) Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis, 7, 1737-1740.
9. Tripodi, A. (2009) Testing for lupus anticoagulants: all that a clinician should know. Lupus, 18, 291-298.